LifeStance Health GroupLFST -1.49%56 Equity-to-Asset is 0.69 as of Mar. 2026, which is at its 10-year median of 0.69. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.25 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 685 Healthcare Providers & Services companies, LifeStance Health Group ranks better than 71.53% on this metric.
The historical rank and industry rank for LifeStance Health Group's Equity-to-Asset or its related term are showing as below:
LFST'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.59 Med: 0.69 Max: 0.81
Current: 0.69
During the past 7 years, the highest Equity to Asset Ratio of LifeStance Health Group was 0.81. The lowest was -0.59. And the median was 0.69.
LFST's Equity-to-Asset is ranked better than 71.53% of 685
companies
in the Healthcare Providers & Services industry
Industry Median: 0.5
vs LFST: 0.69
LifeStance Health Group (NAS:LFST) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
LifeStance Health Group Equity-to-Asset Related Terms
LifeStance Health Group Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LFST vs CON, BKD, OPCH: Equity-to-Asset Comparison
For the Medical Care Facilities subindustry, LifeStance Health Group's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Equity-to-Asset falls into.
LifeStance Health Group Equity-to-Asset Calculation
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
LifeStance Health Group's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group (LFST) has a Equity-to-Asset of 0.69 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on LifeStance Health Group and its competitors. This is near median its historical median of 0.69. According to the industry distribution chart, LifeStance Health Group ranks #195 out of 685 companies in the Healthcare Providers & Services industry, placing it in the top 28.5%.
Is LifeStance Health Group's Equity-to-Asset too high?
LifeStance Health Group's current Equity-to-Asset of 0.69 is near median its 10-year median of 0.69. The Healthcare Providers & Services industry median Equity-to-Asset is 0.50. LifeStance Health Group's value of 0.69 is 38% above this industry median. Based on the distribution chart, LifeStance Health Group ranks #195 out of 685 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Equity-to-Asset compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #195 out of 685 companies for Equity-to-Asset. This puts LifeStance Health Group in the upper half of its industry. The industry median Equity-to-Asset is 0.50. LifeStance Health Group's value of 0.69 is 38% above this benchmark. While the company's 10-year median is 0.69 vs. the industry median of 0.50, LifeStance Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.50, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Equity-to-Asset of 0.69 is 38% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Equity-to-Asset is 0.69, which is near median its own 10-year median of 0.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.25, compared to a current price of $11.27 — trading 36.6% above its estimated fair value. The current Equity-to-Asset is 0.69, which is near median its 10-year median of 0.69 and 38% above the Healthcare Providers & Services industry median of 0.50. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Equity-to-Asset is 0.69 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $11.27 is trading 36.6% above its estimated GF Value™ of $8.25.
GuruFocus considers LifeStance Health Group to be Significantly Overvalued.
Key valuation signals for LFST:
Equity-to-Asset: 0.69 (near median its 10-year median of 0.69)
GF Value™: $8.25 vs. price of $11.27 (36.6% above fair value)
Industry Position: 38% above the Healthcare Providers & Services median (#195 of 685)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score
Get the complete analysis for LFST
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
